Dr. Dan Sotirescu
Claim this profileEphrata Cancer Center
Area of expertise
Non-Small Cell Lung Cancer
Dan Sotirescu has run 3 trials for Non-Small Cell Lung Cancer. Some of their research focus areas include:
Lung Cancer
Dan Sotirescu has run 3 trials for Lung Cancer. Some of their research focus areas include:
Affiliated Hospitals
Ephrata Cancer Center
Adams Cancer Center
Clinical Trials Dan Sotirescu is currently running
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting
2 awards
Phase 3
27 criteria
Perioperative Chemotherapy
for Pancreatic Cancer
This phase III trial compares perioperative chemotherapy (given before and after surgery) versus adjuvant chemotherapy (given after surgery) for the treatment of pancreatic cancer that can be removed by surgery (removable/resectable). Chemotherapy drugs, such as fluorouracil, irinotecan, leucovorin, and oxaliplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving chemotherapy before and after surgery (perioperatively) may work better in treating patients with pancreatic cancer compared to giving chemotherapy after surgery (adjuvantly).
Recruiting
4 awards
Phase 3
18 criteria
More about Dan Sotirescu
Clinical Trial Related
7 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Dan Sotirescu has experience with
- Carboplatin
- Pembrolizumab
- Leucovorin Calcium
- Fluorouracil
- Irinotecan Hydrochloride
- Pemetrexed
Breakdown of trials Dan Sotirescu has run
Non-Small Cell Lung Cancer
Lung Cancer
Colorectal Cancer
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Dan Sotirescu specialize in?
Dan Sotirescu focuses on Non-Small Cell Lung Cancer and Lung Cancer. In particular, much of their work with Non-Small Cell Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Dan Sotirescu currently recruiting for clinical trials?
Yes, Dan Sotirescu is currently recruiting for 3 clinical trials in Ephrata Pennsylvania. If you're interested in participating, you should apply.
Are there any treatments that Dan Sotirescu has studied deeply?
Yes, Dan Sotirescu has studied treatments such as Carboplatin, Pembrolizumab, Leucovorin Calcium.
What is the best way to schedule an appointment with Dan Sotirescu?
Apply for one of the trials that Dan Sotirescu is conducting.
What is the office address of Dan Sotirescu?
The office of Dan Sotirescu is located at: Ephrata Cancer Center, Ephrata, Pennsylvania 17522 United States. This is the address for their practice at the Ephrata Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.